HL-8
HL-8 is a PI3Kα PROTAC degrader. HL-8 promotes the ubiquitination and degradation of PI3Kα. HL-8 reduces pAKT levels. HL-8 has anticancer activity against colon and cervical cancer (Pink: PI3Kα ligand ; Blue: E3 ligase VHL ligand (HY-138678) ; Black: linker (HY-W002042) ).
Product Specifications
CAS Number
2766352-64-9
UNSPSC
12352005
Target
Akt; PI3K; PROTACs
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hl-8.html
Purity
99.17
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC1=NC=C(C=C1NS(=O)(C2=C(C=C(C=C2)F)F)=O)C3=CN4C(C5=NN=C(O5)C6=C(C=CC=C6)C(NCCCCCCC(N[C@@H](C(C)(C)C)C(N7C[C@H](C[C@@H]7C(NCC8=CC=C(C=C8)C9=C(N=CS9)C)=O)O)=O)=O)=O)=CN=C4C=C3
Molecular Formula
C57H59F2N11O9S2
Molecular Weight
1144.27
References & Citations
[1]Wang H, et al. Design, synthesis and activity study of a novel PI3K degradation by hijacking VHL E3 ubiquitin ligase. Bioorg Med Chem. 2022 May 1;61:116707.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSM040938 100 µg
Recombinant Mouse TNFRSF17/BCMA Protein (His & Fc Tag)
Sign In for Pricing
View Details 
![Slc17a6 Mouse Monoclonal Antibody [Clone ID: N29/29]](https://cdn.genprice.uk/products/937/68dd1898061270361e8fb399/imageurl/75-067.webp)
